United States Prostacyclin Analogs Market Report 2016

September 2016 | 123 pages | ID: UC84DF77D9CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Prostacyclin Analogs

Revenue, means the sales value of Prostacyclin Analogs

This report studies sales (consumption) of Prostacyclin Analogs in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Actelion Pharmaceuticals Ltd.
• United Therapeutics Corporation
• Gilead sciences
• Bayer AG
• SteadyMed Ltd.
• GlaxoSmithKline plc
• Pfizer Inc.
• Reata Pharmaceuticals Inc.
• Arena Pharmaceuticals Inc.
• Merck & Co. Inc

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Prostacyclin Analogs in each application, can be divided into

• Health care
• Clinic
• Hospital

Contents

United States Prostacyclin Analogs Market Report 2016

1 PROSTACYCLIN ANALOGS OVERVIEW

1.1 Product Overview and Scope of Prostacyclin Analogs
1.2 Classification of Prostacyclin Analogs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Prostacyclin Analogs
  1.3.1 Health care
  1.3.2 Clinic
  1.3.3 Hospital
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Prostacyclin Analogs (2011-2021)
  1.4.1 USA Prostacyclin Analogs Sales and Growth Rate (2011-2021)
  1.4.2 USA Prostacyclin Analogs Revenue and Growth Rate (2011-2021)

2 USA PROSTACYCLIN ANALOGS COMPETITION BY MANUFACTURERS

2.1 USA Prostacyclin Analogs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Prostacyclin Analogs Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Prostacyclin Analogs Average Price by Manufactures (2015 and 2016)
2.4 Prostacyclin Analogs Market Competitive Situation and Trends
  2.4.1 Prostacyclin Analogs Market Concentration Rate
  2.4.2 Prostacyclin Analogs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA PROSTACYCLIN ANALOGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Prostacyclin Analogs Sales and Market Share by Type (2011-2016)
3.2 USA Prostacyclin Analogs Revenue and Market Share by Type (2011-2016)
3.3 USA Prostacyclin Analogs Price by Type (2011-2016)
3.4 USA Prostacyclin Analogs Sales Growth Rate by Type (2011-2016)

4 USA PROSTACYCLIN ANALOGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Prostacyclin Analogs Sales and Market Share by Application (2011-2016)
4.2 USA Prostacyclin Analogs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA PROSTACYCLIN ANALOGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Actelion Pharmaceuticals Ltd.
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Prostacyclin Analogs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Actelion Pharmaceuticals Ltd. Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 United Therapeutics Corporation
  5.2.2 Prostacyclin Analogs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 United Therapeutics Corporation Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Gilead sciences
  5.3.2 Prostacyclin Analogs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Gilead sciences Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Bayer AG
  5.4.2 Prostacyclin Analogs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Bayer AG Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 SteadyMed Ltd.
  5.5.2 Prostacyclin Analogs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 SteadyMed Ltd. Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 GlaxoSmithKline plc
  5.6.2 Prostacyclin Analogs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 GlaxoSmithKline plc Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Pfizer Inc.
  5.7.2 Prostacyclin Analogs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Pfizer Inc. Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Reata Pharmaceuticals Inc.
  5.8.2 Prostacyclin Analogs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Reata Pharmaceuticals Inc. Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Arena Pharmaceuticals Inc.
  5.9.2 Prostacyclin Analogs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Arena Pharmaceuticals Inc. Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Merck & Co. Inc
  5.10.2 Prostacyclin Analogs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Merck & Co. Inc Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 PROSTACYCLIN ANALOGS MANUFACTURING COST ANALYSIS

6.1 Prostacyclin Analogs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Prostacyclin Analogs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Prostacyclin Analogs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Prostacyclin Analogs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA PROSTACYCLIN ANALOGS MARKET FORECAST (2016-2021)

10.1 USA Prostacyclin Analogs Sales, Revenue Forecast (2016-2021)
10.2 USA Prostacyclin Analogs Sales Forecast by Type (2016-2021)
10.3 USA Prostacyclin Analogs Sales Forecast by Application (2016-2021)
10.4 Prostacyclin Analogs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prostacyclin Analogs
Table Classification of Prostacyclin Analogs
Figure USA Sales Market Share of Prostacyclin Analogs by Type in 2015
Table Application of Prostacyclin Analogs
Figure USA Sales Market Share of Prostacyclin Analogs by Application in 2015
Figure Health care Examples
Figure Clinic Examples
Figure Hospital Examples
Figure USA Prostacyclin Analogs Sales and Growth Rate (2011-2021)
Figure USA Prostacyclin Analogs Revenue and Growth Rate (2011-2021)
Table USA Prostacyclin Analogs Sales of Key Manufacturers (2015 and 2016)
Table USA Prostacyclin Analogs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prostacyclin Analogs Sales Share by Manufacturers
Figure 2016 Prostacyclin Analogs Sales Share by Manufacturers
Table USA Prostacyclin Analogs Revenue by Manufacturers (2015 and 2016)
Table USA Prostacyclin Analogs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Prostacyclin Analogs Revenue Share by Manufacturers
Table 2016 USA Prostacyclin Analogs Revenue Share by Manufacturers
Table USA Market Prostacyclin Analogs Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Prostacyclin Analogs Average Price of Key Manufacturers in 2015
Figure Prostacyclin Analogs Market Share of Top 3 Manufacturers
Figure Prostacyclin Analogs Market Share of Top 5 Manufacturers
Table USA Prostacyclin Analogs Sales by Type (2011-2016)
Table USA Prostacyclin Analogs Sales Share by Type (2011-2016)
Figure USA Prostacyclin Analogs Sales Market Share by Type in 2015
Table USA Prostacyclin Analogs Revenue and Market Share by Type (2011-2016)
Table USA Prostacyclin Analogs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Prostacyclin Analogs by Type (2011-2016)
Table USA Prostacyclin Analogs Price by Type (2011-2016)
Figure USA Prostacyclin Analogs Sales Growth Rate by Type (2011-2016)
Table USA Prostacyclin Analogs Sales by Application (2011-2016)
Table USA Prostacyclin Analogs Sales Market Share by Application (2011-2016)
Figure USA Prostacyclin Analogs Sales Market Share by Application in 2015
Table USA Prostacyclin Analogs Sales Growth Rate by Application (2011-2016)
Figure USA Prostacyclin Analogs Sales Growth Rate by Application (2011-2016)
Table Actelion Pharmaceuticals Ltd. Basic Information List
Table Actelion Pharmaceuticals Ltd. Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actelion Pharmaceuticals Ltd. Prostacyclin Analogs Sales Market Share (2011-2016)
Table United Therapeutics Corporation Basic Information List
Table United Therapeutics Corporation Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Therapeutics Corporation Prostacyclin Analogs Sales Market Share (2011-2016)
Table Gilead sciences Basic Information List
Table Gilead sciences Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead sciences Prostacyclin Analogs Sales Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer AG Prostacyclin Analogs Sales Market Share (2011-2016)
Table SteadyMed Ltd. Basic Information List
Table SteadyMed Ltd. Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table SteadyMed Ltd. Prostacyclin Analogs Sales Market Share (2011-2016)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline plc Prostacyclin Analogs Sales Market Share (2011-2016)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc. Prostacyclin Analogs Sales Market Share (2011-2016)
Table Reata Pharmaceuticals Inc. Basic Information List
Table Reata Pharmaceuticals Inc. Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reata Pharmaceuticals Inc. Prostacyclin Analogs Sales Market Share (2011-2016)
Table Arena Pharmaceuticals Inc. Basic Information List
Table Arena Pharmaceuticals Inc. Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals Inc. Prostacyclin Analogs Sales Market Share (2011-2016)
Table Merck & Co. Inc Basic Information List
Table Merck & Co. Inc Prostacyclin Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Inc Prostacyclin Analogs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostacyclin Analogs
Figure Manufacturing Process Analysis of Prostacyclin Analogs
Figure Prostacyclin Analogs Industrial Chain Analysis
Table Raw Materials Sources of Prostacyclin Analogs Major Manufacturers in 2015
Table Major Buyers of Prostacyclin Analogs
Table Distributors/Traders List
Figure USA Prostacyclin Analogs Production and Growth Rate Forecast (2016-2021)
Figure USA Prostacyclin Analogs Revenue and Growth Rate Forecast (2016-2021)
Table USA Prostacyclin Analogs Production Forecast by Type (2016-2021)
Table USA Prostacyclin Analogs Consumption Forecast by Application (2016-2021)